Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurochem ; 79(1): 130-42, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11595765

ABSTRACT

Monitoring the release and uptake of catecholamines from terminals in weakly innervated brain regions is an important step in understanding their importance in normal brain function. To that end, we have labeled brain slices from transgenic mice that synthesize placental alkaline phosphatase (PLAP) on neurons containing tyrosine hydroxylase with antibody-fluorochrome conjugate, PLAP-Cy5. Excitation of the fluorochrome enables catecholamine neurons to be visualized in living tissue. Immunohistochemical fluorescence with antibodies to tyrosine hydroxylase and dopamine beta-hydroxylase revealed that the PLAP labeling was specific to catecholamine neurons. In the prefrontal cortex (PFC), immunohistochemical fluorescence of the PLAP along with staining for dopamine transporter (DAT) and norepinephrine transporter (NET) revealed that all three exhibit remarkable spatial overlap. Fluorescence from the PLAP antibody was used to position carbon-fiber microelectrodes adjacent to catecholamine neurons in the PFC. Following incubation with L-DOPA, catecholamine release and subsequent uptake was measured and the effect of uptake inhibitors examined. Release and uptake in NET and DAT knockout mice were also monitored. Uptake rates in the cingulate and prelimbic cortex are so slow that catecholamines can exist in the extracellular fluid for sufficient time to travel approximately 100 microm. The results support heterologous uptake of catecholamines and volume transmission in the PFC of mice.


Subject(s)
Catecholamines/metabolism , Membrane Glycoproteins , Membrane Transport Proteins , Nerve Tissue Proteins , Prefrontal Cortex/metabolism , Symporters , Alkaline Phosphatase/biosynthesis , Alkaline Phosphatase/genetics , Alkaline Phosphatase/immunology , Animals , Antibodies, Monoclonal , Carbocyanines , Carrier Proteins/antagonists & inhibitors , Carrier Proteins/genetics , Carrier Proteins/immunology , Chromatography, High Pressure Liquid , Dopamine Plasma Membrane Transport Proteins , Electric Stimulation , Electrochemistry , Fluorescent Antibody Technique , Gyrus Cinguli/metabolism , Limbic System/metabolism , Mice , Mice, Knockout , Mice, Transgenic , Microscopy, Confocal , Monoamine Oxidase Inhibitors/pharmacology , Neurons/enzymology , Norepinephrine Plasma Membrane Transport Proteins , Placenta/enzymology , Tyrosine 3-Monooxygenase/analysis
2.
J Biol Chem ; 275(13): 9136-42, 2000 Mar 31.
Article in English | MEDLINE | ID: mdl-10734047

ABSTRACT

Effects of vesicular monoamine transporter inhibitors on catecholamine release from bovine chromaffin cells have been examined at the level of individual exocytotic events. As expected for a depletion of vesicular stores, release evoked by depolarizing agents was decreased following 15-min incubations with reserpine and tetrabenazine, as evidenced by a decrease in exocytotic frequency and amount released per event. In contrast, two reserpine derivatives, methyl reserpate and reserpic acid, were much less effective. Surprisingly, the incubations also decreased the accompanying rise in intracellular Ca(2+) evoked by depolarizing agents. Subcellular studies revealed that reserpine and tetrabenazine at concentrations near their K(i) values not only could increase cytoplasmic catecholamines but also could displace Ca(2+) from vesicles. Furthermore, transient exposure to tetrabenazine and reserpine, but not methyl reserpate and reserpic acid, induced exocytotic release of catecholamines. Reserpine induced a rise in intracellular Ca(2+), as detected by whole-cell measurements with Fura-2. It could induce exocytosis, albeit at a lower frequency, in Ca(2+)-free solutions, supporting an internal Ca(2+) source. Depletion of endoplasmic reticulum and mitochondrial Ca(2+) pools did not eliminate the reserpine-activated release. These results indicate that vesicular Ca(2+) can play an important role in exocytosis and under some conditions may be involved in initiating this process.


Subject(s)
Calcium/metabolism , Exocytosis , Membrane Transport Proteins , Neuropeptides , Animals , Biological Transport , Catalysis , Catecholamines/metabolism , Cattle , Cells, Cultured , Cytoplasm/metabolism , Exocytosis/drug effects , Membrane Glycoproteins/antagonists & inhibitors , Membrane Glycoproteins/metabolism , Potassium/metabolism , Reserpine/pharmacology , Vesicular Biogenic Amine Transport Proteins , Vesicular Monoamine Transport Proteins
3.
J Neurochem ; 73(6): 2397-405, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10582599

ABSTRACT

The vesicular contents in bovine chromaffin cells are maintained at high levels owing to the strong association of its contents, which is promoted by the low vesicular pH. The association is among the catecholamines, Ca2+, ATP, and vesicular proteins. It was found that transient application of a weak base, methylamine (30 mM), amphetamine (10 microM), or tyramine (10 microM), induced exocytotic release. Exposure to these agents was also found to increase both cytosolic catecholamine and intracellular Ca2+ concentration, as measured by amperometry and fura-2 fluorescence. Amphetamine, the most potent amine with respect to evoking exocytosis, was found to be effective even in buffer without external Ca2+; however, the occurrence of spikes was suppressed when BAPTA-acetoxymethyl ester was used to complex intracellular Ca2+. Amphetamine-induced spikes in Ca2+-free medium were not suppressed by thapsigargin or ruthenium red, inhibitors of the sarco(endo)plasmic reticulum Ca2+-ATPase and mitochondrial Ca2+ stores. Atomic absorption measurements of amphetamine- and methylamine-treated vesicles reveal that intravesicular Ca2+ stores are decreased after a 15-min incubation. Taken together, these data indicate that amphetamine and methylamine can disrupt vesicular stores to a sufficient degree that Ca2+ can escape and trigger exocytosis.


Subject(s)
Adrenal Medulla/drug effects , Alkalies/pharmacology , Amphetamine/pharmacology , Calcium Signaling/drug effects , Exocytosis/drug effects , Methylamines/pharmacology , Tyramine/pharmacology , Adenosine Triphosphate/metabolism , Adrenal Medulla/metabolism , Animals , Calcium/metabolism , Catecholamines/metabolism , Cattle , Cytosol/drug effects , Cytosol/metabolism , Hydrogen-Ion Concentration , Mitochondria/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...